Exploration of the Prognostic and Immunotherapeutic Value of B and T Lymphocyte Attenuator in Skin Cutaneous Melanoma

B and T lymphocyte attenuator (BTLA) is a newly identified immune checkpoint molecular belonging to the CD28 immunoglobulin superfamily. However, the expression and clinical value of BTLA in skin cutaneous melanoma (SKCM) has not been widely characterized. We found that BTLA levels were upregulated...

Full description

Saved in:
Bibliographic Details
Published in:Front Oncol
Main Authors: Dong, Xubin, Song, Jingjing, Chen, Buran, Qi, Yufeng, Jiang, Wenjie, Li, Huihui, Zheng, Danni, Wang, Yinghao, Zhang, Xiaohua, Liu, Haiguang
Format: Artigo
Language:Inglês
Published: Frontiers Media S.A. 2021
Subjects:
Oncology
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7953043/
https://ncbi.nlm.nih.gov/pubmed/33718105
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.592811
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items